Co-CEO talks breakthrough test to treat technology amid new variant, ‘tripledemic’

February 9, 2023

Co-CEO talks breakthrough test to treat tech amid new variant, ‘tripledemic’

Our co-CEO, Ron Gutman, speaks out about a new strain of COVID-19 (XBB.1.5) that is causing concern due to a potential surge in cases. With a "tripledemic" of COVID-19, the flu, and RSV, Gutman is advocating for proactive measures to protect against the virus through "test and treat" solutions.

What is the strain of COVID-19 - XBB.1.5?

The ongoing COVID-19 pandemic has been further complicated by the emergence of new strains of the virus, including the XBB.1.5. This strain has been shown to spread more rapidly than previous variants and has already been identified as a cause of increased cases in some areas. 

What is the impact of the new variant plus the “tripledemic”?

The "tripledemic" of COVID-19, the flu, and RSV is causing ongoing difficulties in controlling the spread of infectious diseases. To help address this, Intrivo has launched a national public service campaign to raise awareness of the new variant and provide options for protecting Americans. 

How can I protect myself in case I get COVID-19 (XBB.1.5)?

To monitor if you have COVID-19 (XBB.1.5), consider keeping an at-home rapid antigen test  for self-administration. Accurate results can be obtained within minutes. If testing positive, utilizing a "Test to Treat" App solution can aid in a faster recovery. This includes seeing a healthcare provider through telehealth, receiving an FDA approved antiviral medication (if eligible), and having the prescription delivered to your doorstep, all without leaving your home. 

Where can I get more help or information?

Call our friendly Customer Service Team at 888-965-0301! Their hours of operation are Mon. - Fri., 10 am - 4 pm EST.

For more insights on the latest COVID-19 variants, watch co-CEO Ron Gutman’s full interview with Everyday Northwest by clicking the link here.

You might also like